Robert A. Ramirez

4.6k citations
62 papers · 3.7k · 2 hit papers · h-index 20

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Chemokine receptors and signaling
    • Lung Cancer Research Studies

Papers in

    • Neuroendocrine Tumor Research Advances 34
    • Cancer Immunotherapy and Biomarkers 4
    • Pancreatic and Hepatic Oncology Research 3
    • Cancer survivorship and care 2
    • COVID-19 and healthcare impacts 2

Robert A. Ramirez

58 papers receiving 3.7k citations

Robert A. Ramirez's Hit Papers

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial 2020 · 454 citations
4540+2+5Years since publication5001k1.5k2k

Peers

Robert A. Ramirez
Comparison fields: 5 of 72
  • Hepatology 1.5k
  • Oncology 1.3k
  • Epidemiology 555
  • Pulmonary and Respiratory Medicine 377
  • Immunology 203
Replace Jun Itakura with:
Jun Itakura Japan
Kazuyoshi Ohkawa Japan
Ganesh Gunasekaran United States
Shinichi Ohkawa Japan
Mee–Yon Cho South Korea
Gui‐Qi Zhu China
Junye Wang China
Shinji Osada Japan
Hyung‐Don Kim South Korea
Kazuo Hatsuse Japan
Robert A. Ramirez relative to Jun Itakura Japan Jun Itakura's profile →
Citations per field
00.5×2×2.7×
Jun Itakura · 1×
Citations per year

Countries citing papers authored by Robert A. Ramirez

Since Specialization
Citations

This map shows the geographic impact of Robert A. Ramirez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Ramirez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Ramirez more than expected).

Fields of papers citing papers by Robert A. Ramirez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Ramirez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Ramirez. The network helps show where Robert A. Ramirez may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Ramirez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Ramirez Line = papers co-authored together Robert A. Ramirez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Hit paper breakdown →
20182094
2
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Hit paper breakdown →
2020454
3 2022104
4 201291
5 202089
6 201678
7 202070
8
Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
200268
9 201767
10 200750
11 201650
12 202046
13 201935
14 201733
15 201232
16 201528
17
Molecular Targets in Non-Small Cell Lung Cancer.
201726
18 201926
19 201223
20 202220

About Robert A. Ramirez

Robert A. Ramirez is a scholar working on Epidemiology, Oncology, Pulmonary and Respiratory Medicine, Radiation and Hepatology, having authored 62 papers that have together received 3.7k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (34 papers), Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer survivorship and care (2 papers), COVID-19 and healthcare impacts (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Hepatology (1.5k citations), Oncology (1.3k citations), Epidemiology (555 citations), Pulmonary and Respiratory Medicine (377 citations) and Immunology (203 citations). Robert A. Ramirez has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Aman Chauhan, Eugene A. Woltering, Katharine E. H. Thomas, J. Philip Boudreaux, Yi‐Zarn Wang, Raymond Uyiosa Osarogiagbon, Xinhua Yu, Ramcharan Thiagarajan, Allen D. Berry and Laura Elizabeth Miller. Their work appears in journals such as Translational Lung Cancer Research, Journal of Thoracic Oncology, Pancreas, The Oncologist and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact